Control of Diabetic Vascular Endothelial Function

Exploring the cause of diabetic vascular disease

Full Project Name:Control of Diabetic Vascular Endothelial Function by Mitochondial Fission ProteinsPrincipal Investigator:Michael Widlansky, MD, MedicineCo-Investigator:R. Blake Hill, PhD, BiochemistryAward Amount:$199,569
Award Date
January2016
Project Duration:24 months

Project Description Narrative:


More than 380 million people worldwide have diabetes. In Wisconsin, more than 1,100 residents die from diabetes and many more suffer disabling complications caused by diabetes, including vascular disease related to blood vessel abnormalities. Currently, therapies to combat vascular disease are much less effective in patients with diabetes, and new therapies that specifically target diabetic vascular disease may help reduce the risk of illness and death in patients with diabetes.

Through this award, investigators will explore the root of diabetic vascular disease, endothelial function, to identify and validate a new class of pharmacological inhibitors that could be used therapeutically to reduce diabetic vascular morbidity.

Outcomes & Lessons Learned:


Project successfully earned extramural funding to support project goals and aims prior to start date. Therefore, AHW funding was rescinded.

AHW Logo

8701 W Watertown Plank Road,
Milwaukee, WI 53226-0509
(414) 955-4350

©2019 MEDICAL COLLEGE OF WISCONSIN. ALL RIGHTS RESERVED | MCW.EDU | TERMS & PRIVACY | NON-DISCRIMINATION NOTICE | CONTACT US

top